The trajectory of companies tied to Viagra's history presents a challenging investment picture . While the initial success generated substantial gains, generic copies have significantly impacted revenue. Investing in connected pharmaceutical companies now requires a discerning assessment of intellectual property rights , evolving medical trends , a